EHA Innovation Grant

The call for applications is closed. It will open again in October 2025. 

EHA Innovation Grants encourage and support the: 

  • Creation of consortia 
  • Generation of preliminary data that can then be used to apply for larger funding opportunities 

The grants: 

  • Support high-quality clinical or translational research in hematology 
  • Last for a period of two years 
  • Can provide a total award of up to €300,000 for the whole consortium 

To reflect the collaborative spirit of the grant, no more than 40% of the total grant should be allocated to one member of the consortium. 

Eligibility

  • Every principal investigator (PI) must be an EHA member. 
  • All PIs must be conducting high-quality clinical or translational research. Basic and/or translational researchers can also be included, but the general focus of the project must remain clinical and translational.  
  • All PIs must be independent researchers or group leaders and have full appointments at academic institutes or proven equivalents in Europe. 
  • Each consortium must include at least three PIs operating in at least three different countries in Europe. 
  • At least one of the PIs must operate in of the following countries: Albania, Armenia, Azerbaijan, Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Estonia, Georgia, Hungary, Kosovo, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Poland, Portugal, Romania, Serbia, Slovak Republic, Slovenia, Türkiye, Ukraine. 
  • At least one of the PIs must be a junior independent group leader, within five years of conducting independent research. 
  • The outcomes of your project must serve as the basis for applying to larger research projects (e.g. HORIZON EUROPE, EIC ACCELERATOR). For this reason, you must indicate in your research proposal what funding opportunity you’ll target using the data from your grant-supported project. 
  • You must state a connection to one or more EHA Specialized Working Groups (SWGs) in your application. For example, as part of your application, you might indicate that PIs are members of an EHA SWG or include a letter of endorsement from an EHA SWG Chair. 
  • You must form your consortium within a maximum of one year of the closing date listed above.  
  • If you plan to receive funding in addition to the requested EHA support, you must specify this in your project proposal. Additional funding can come from public or philanthropic institutions, but it cannot come from industry or for-profit entities. 

If you have questions about eligibility, please send us an email [email EHA-Grants@ecorys.com] before you apply. 

What an EHA Innovation Grant covers

You can use your grant for: 

  • Personnel costs, including the applicant or the costs of hiring other research staff to work directly on the project 
  • Lab consumables 
  • Small equipment  
  • Miscellaneous expenses, such as publication of your project’s results 

You must use some of your grant to pay for:  

  • Attendance at the EHA Congress whilst your project is active (maximum €2,000 per PI per year)  
  • A final audit of your project’s financial costs (maximum €2,000 per PI)  

You cannot use your grant to cover: 

  • Overhead costs  
  • Excessive travel costs 
  • Costs that are covered by another fund, even if new funding is acquired during the project, that make all or part of the grant redundant 

If you acquire additional funding, you must email us [link to grants@ehaweb.org] about this within 30 days of its awarding. You must also tell us how you’ll use the grants together.    

Share